ARMISTICE CAPITAL, LLC
13F Reported Value
ⓘ$8.2B
incl. option notional
Equity Holdings
ⓘ$3.6B
Option Notional
ⓘ$4.6B
$4.1B puts / $426.6M calls
Holdings
333
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
ARMISTICE CAPITAL, LLC disclosed 333 positions worth $8.2B in its Form 13F-HR for Q2 2026 — $3.6B in common stock plus $4.6B of put/call option positions (reported at underlying notional value, not premium at risk), led by $SPY (SPDR S&P 500 ETF TRUST) puts. During the quarter the fund opened 170 new positions and exited 99 — including a new stake in $TVTX and a full exit from $AVNS. The portfolio is most concentrated in Healthcare (64.6% of disclosed assets). All figures are sourced directly from ARMISTICE CAPITAL, LLC’s Form 13F-HR filing with the SEC under CIK 1601086.
AI Fund Analysis
Diversifying
Sector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$2.4B3,200,000 sh ISHARES TR - RUSSELL 2000 ETF PUT
—Quality
$1.7B5,800,000 sh- 40.7#2,092
Quality
$154.6M288,000 sh - 28.1
Quality
$130.3M1,530,000 sh - 41.9
Quality
$123.1M2,646,201 sh - 26.9
Quality
$104.3M2,810,000 sh - 28.1
Quality
$102.3M1,201,342 sh - 77.4
Quality
$102.0M900,005 sh - 76.5
Quality
$90.3M535,838 sh - 56.6
Quality
$89.3M1,572,539 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 SPDR S&P 500 ETF TRUST$SPYPUT | — | $2.4B | 3,200,000 |
| ISHARES TR - RUSSELL 2000 ETF PUT | — | $1.7B | 5,800,000 |
 MADRIGAL PHARMACEUTICALS, INC.$MDGL | 40.7#2,092 | $154.6M | 288,000 |
 CYTOKINETICS INC$CYTKCALL | 28.1 | $130.3M | 1,530,000 |
 SUPERNUS PHARMACEUTICALS, INC.$SUPN | 41.9 | $123.1M | 2,646,201 |
 AGIOS PHARMACEUTICALS, INC.$AGIOCALL | 26.9 | $104.3M | 2,810,000 |
| CYTOKINETICS INC$CYTK | 28.1 | $102.3M | 1,201,342 |
 INCYTE CORP$INCY | 77.4 | $102.0M | 900,005 |
 NEUROCRINE BIOSCIENCES INC$NBIX | 76.5 | $90.3M | 535,838 |
 Travere Therapeutics, Inc.$TVTX | 56.6 | $89.3M | 1,572,539 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of ARMISTICE CAPITAL, LLC's 333 positions.
Showing top 10 of 333 holdings.
Sector Allocation
Healthcare
$2.3B
Technology
$785.9M
Consumer Discretionary
$241.8M
Consumer Staples
$118.6M
Industrials
$53.4M
Communication Services
$43.1M
Other
$12.9M
Materials
$8.8M
Top Holdings — ARMISTICE CAPITAL, LLC (Q2 2026)
Top 150 of 333 disclosed positions (by reported value) from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $SPYPUT | SPDR S&P 500 ETF TRUST | $2.4B | — | +52% | — |
| 2 | — | ISHARES TR - RUSSELL 2000 ETF | $1.7B | — | +66% | — |
| 3 | $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $154.6M | 4.3% | +9% | 40.7 |
| 4 | $CYTKCALL | CYTOKINETICS INC | $130.3M | — | -10% | 28.1 |
| 5 | $SUPN | SUPERNUS PHARMACEUTICALS, INC. | $123.1M | 3.4% | +40% | 41.9 |
| 6 | $AGIOCALL | AGIOS PHARMACEUTICALS, INC. | $104.3M | — | -12% | 26.9 |
| 7 | $CYTK | CYTOKINETICS INC | $102.3M | 2.8% | +57% | 28.1 |
| 8 | $INCY | INCYTE CORP | $102.0M | 2.8% | +37% | 77.4 |
| 9 | $NBIX | NEUROCRINE BIOSCIENCES INC | $90.3M | 2.5% | -26% | 76.5 |
| 10 | $TVTX | Travere Therapeutics, Inc. | $89.3M | 2.5% | -68% | 56.6 |
| 11 | $AGIO | AGIOS PHARMACEUTICALS, INC. | $89.1M | 2.5% | -12% | 26.9 |
| 12 |  $PTCT | PTC THERAPEUTICS, INC. | $87.4M | 2.4% | -48% | 35.4 |
| 13 |  $UNH | UNITEDHEALTH GROUP INC | $76.1M | 2.1% | +24% | 62.7 |
| 14 |  $FRPT | Freshpet, Inc. | $74.5M | 2.1% | +15% | 61.1 |
| 15 |  $DYN | Dyne Therapeutics, Inc. | $68.6M | 1.9% | -3% | — |
| 16 |  $AMZN | AMAZON COM INC | $67.8M | 1.9% | +9% | 68.7 |
| 17 |  $IMVT | Immunovant, Inc. | $66.9M | 1.9% | -51% | — |
| 18 |  $RIGL | RIGEL PHARMACEUTICALS INC | $65.4M | 1.8% | +31% | 73.9 |
| 19 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $61.4M | 1.7% | +34% | 65.1 |
| 20 |  $IRWD | IRONWOOD PHARMACEUTICALS INC | $58.7M | 1.6% | -7% | 60.8 |
| 21 |  $HRMY | Harmony Biosciences Holdings, Inc. | $56.9M | 1.6% | -4% | 71.4 |
| 22 |  $REGN | REGENERON PHARMACEUTICALS, INC. | $56.0M | 1.6% | +149% | 71 |
| 23 | $PTCTCALL | PTC THERAPEUTICS, INC. | $53.8M | — | +69% | 35.4 |
| 24 |  $NKTR | NEKTAR THERAPEUTICS | $50.5M | 1.4% | +25% | 9.7 |
| 25 |  $MLYS | Mineralys Therapeutics, Inc. | $46.8M | 1.3% | +48% | — |
| 26 | $IMVTCALL | Immunovant, Inc. | $46.2M | — | -37% | — |
| 27 |  $SNY | Sanofi | $45.4M | 1.3% | +255% | — |
| 28 |  $IMCR | Immunocore Holdings plc | $45.3M | 1.3% | +20% | — |
| 29 |  $GOOG | Alphabet Inc. | $45.2M | 1.3% | +7% | 78.2 |
| 30 |  $SLDB | Solid Biosciences Inc. | $42.7M | 1.2% | +34% | — |
| 31 |  $MDB | MongoDB, Inc. | $42.0M | 1.2% | +17% | 68.8 |
| 32 |  $KURA | Kura Oncology, Inc. | $40.3M | 1.1% | -2% | 27.6 |
| 33 |  $XRAY | DENTSPLY SIRONA Inc. | $39.0M | 1.1% | +22% | 39.8 |
| 34 |  $UBER | Uber Technologies, Inc | $35.9M | 1.0% | -4% | 73.5 |
| 35 |  $AXGN | Axogen, Inc. | $35.8M | 1.0% | -17% | 40.8 |
| 36 |  $IRON | Disc Medicine, Inc. | $33.6M | 0.9% | -14% | — |
| 37 |  $GTLB | Gitlab Inc. | $32.8M | 0.9% | +4% | 56.8 |
| 38 |  $FIVN | Five9, Inc. | $32.7M | 0.9% | -4% | 59.7 |
| 39 |  $HUBS | HUBSPOT INC | $32.5M | 0.9% | +38% | 70.4 |
| 40 |  $ALGN | ALIGN TECHNOLOGY INC | $30.4M | 0.8% | +14% | 58.9 |
| 41 |  $MSFT | MICROSOFT CORP | $30.1M | 0.8% | +65% | 79.8 |
| 42 |  $OFIX | Orthofix Medical Inc. | $29.8M | 0.8% | +21% | 38.2 |
| 43 |  $HUM | HUMANA INC | $28.8M | 0.8% | -49% | 58.9 |
| 44 |  $ANGO | ANGIODYNAMICS INC | $28.6M | 0.8% | +18% | 28.7 |
| 45 | $TVTXCALL | Travere Therapeutics, Inc. | $28.4M | — | NEW | 56.6 |
| 46 |  $WAT | WATERS CORP /DE/ | $28.1M | 0.8% | NEW | 60.4 |
| 47 | $MLYSCALL | Mineralys Therapeutics, Inc. | $28.1M | — | NEW | — |
| 48 |  $SCALL | SentinelOne, Inc. | $27.2M | — | -3% | 44.4 |
| 49 |  $VSTM | Verastem, Inc. | $26.8M | 0.7% | +53% | 29.7 |
| 50 |  $FDMT | 4D Molecular Therapeutics, Inc. | $26.6M | 0.7% | +0% | 34.5 |
| 51 |  $NTLA | Intellia Therapeutics, Inc. | $25.4M | 0.7% | +346% | 19.9 |
| 52 |  $WYNN | WYNN RESORTS LTD | $25.3M | 0.7% | +50% | — |
| 53 |  $TMCI | TREACE MEDICAL CONCEPTS, INC. | $25.3M | 0.7% | +0% | 25.6 |
| 54 |  $AUTL | Autolus Therapeutics plc | $24.0M | 0.7% | -5% | — |
| 55 |  $ARVN | ARVINAS, INC. | $23.2M | 0.6% | +41% | 36.6 |
| 56 |  $MGNX | MACROGENICS INC | $23.1M | 0.6% | -17% | 39.6 |
| 57 |  $ANRO | Alto Neuroscience, Inc. | $22.8M | 0.6% | -5% | — |
| 58 |  $TOST | Toast, Inc. | $22.6M | 0.6% | +40% | 69.5 |
| 59 |  $PATH | UiPath, Inc. | $21.7M | 0.6% | +56% | 69.9 |
| 60 |  $GRFS | Grifols SA | $20.8M | 0.6% | -2% | — |
| 61 |  $CENT | CENTRAL GARDEN & PET CO | $20.8M | 0.6% | +12% | 49.7 |
| 62 |  $TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $20.8M | 0.6% | -29% | — |
| 63 | $S | SentinelOne, Inc. | $20.5M | 0.6% | -36% | 44.4 |
| 64 |  $LEN | LENNAR CORP /NEW/ | $20.0M | 0.6% | +25% | 47.2 |
| 65 |  $ISRG | INTUITIVE SURGICAL INC | $19.4M | 0.5% | -6% | 79.9 |
| 66 |  $RH | RH | $19.2M | 0.5% | +143% | 55.2 |
| 67 |  $ZETA | Zeta Global Holdings Corp. | $19.0M | 0.5% | +8678% | 63.4 |
| 68 |  $WDAY | Workday, Inc. | $18.9M | 0.5% | +108% | 75.5 |
| 69 |  $NBIS | Nebius Group N.V. | $18.5M | 0.5% | -38% | — |
| 70 |  $INTC | INTEL CORP | $18.0M | 0.5% | -42% | 45.6 |
| 71 |  $BABA | Alibaba Group Holding Ltd | $16.1M | 0.5% | -18% | — |
| 72 |  $ILMN | ILLUMINA, INC. | $16.0M | 0.4% | NEW | 60.4 |
| 73 |  $PBH | Prestige Consumer Healthcare Inc. | $15.9M | 0.4% | NEW | 53.7 |
| 74 |  $GSK | GSK plc | $15.7M | 0.4% | +27% | — |
| 75 |  $FWONA | Liberty Media Corp | $15.7M | 0.4% | NEW | 63.2 |
| 76 |  $ITGR | Integer Holdings Corp | $15.7M | 0.4% | NEW | 55.9 |
| 77 |  $CPRI | Capri Holdings Ltd | $15.5M | 0.4% | +27% | — |
| 78 |  $XERS | Xeris Biopharma Holdings, Inc. | $15.5M | 0.4% | +3% | 56.5 |
| 79 |  $SRRK | Scholar Rock Holding Corp | $15.3M | 0.4% | -17% | — |
| 80 |  $LYV | Live Nation Entertainment, Inc. | $15.0M | 0.4% | NEW | 52.9 |
| 81 |  $NVO | NOVO NORDISK A S | $15.0M | 0.4% | NEW | — |
| 82 |  $TWST | Twist Bioscience Corp | $14.6M | 0.4% | NEW | 33.9 |
| 83 |  $APP | AppLovin Corp | $14.5M | 0.4% | +16% | 84.4 |
| 84 |  $BCYC | BICYCLE THERAPEUTICS PLC | $14.4M | 0.4% | +0% | — |
| 85 |  $PENN | PENN Entertainment, Inc. | $14.4M | 0.4% | -57% | 41.2 |
| 86 |  $BMY | BRISTOL MYERS SQUIBB CO | $13.5M | 0.4% | +14% | 70.4 |
| 87 |  $BBOT | BridgeBio Oncology Therapeutics, Inc. | $13.4M | 0.4% | +33% | — |
| 88 |  $CROX | Crocs, Inc. | $13.4M | 0.4% | -28% | 58 |
| 89 |  $MU | MICRON TECHNOLOGY INC | $13.4M | 0.4% | -50% | 86.2 |
| 90 |  $BE | Bloom Energy Corp | $13.2M | 0.4% | -9% | 66.2 |
| 91 |  $VERA | Vera Therapeutics, Inc. | $12.9M | 0.4% | +1% | — |
| 92 |  $TTWO | TAKE TWO INTERACTIVE SOFTWARE INC | $12.5M | 0.3% | NEW | 55.6 |
| 93 |  $SYRE | Spyre Therapeutics, Inc. | $12.2M | 0.3% | +14% | — |
| 94 |  $KYMR | Kymera Therapeutics, Inc. | $12.2M | 0.3% | +27% | 28.4 |
| 95 |  $VYGR | Voyager Therapeutics, Inc. | $12.0M | 0.3% | -2% | 8.1 |
| 96 |  $MRVL | Marvell Technology, Inc. | $11.9M | 0.3% | NEW | 76.5 |
| 97 |  $TER | TERADYNE, INC | $11.9M | 0.3% | -44% | 77.3 |
| 98 |  $GNRC | GENERAC HOLDINGS INC. | $11.7M | 0.3% | -11% | 54.4 |
| 99 |  $RDDT | Reddit, Inc. | $11.6M | 0.3% | -4% | 79.8 |
| 100 |  $NUVB | Nuvation Bio Inc. | $11.4M | 0.3% | +15% | 37.9 |
| 101 |  $BSX | BOSTON SCIENTIFIC CORP | $11.3M | 0.3% | NEW | 77.5 |
| 102 |  $ELF | e.l.f. Beauty, Inc. | $11.3M | 0.3% | +176% | 58.2 |
| 103 |  $NOK | NOKIA CORP | $11.3M | 0.3% | NEW | — |
| 104 |  $NPCE | NeuroPace Inc | $11.0M | 0.3% | +0% | 32.4 |
| 105 |  $NTSK | Netskope Inc | $10.9M | 0.3% | NEW | 34.7 |
| 106 |  $ABNB | Airbnb, Inc. | $10.7M | 0.3% | +392% | 71 |
| 107 |  $FOXA | Fox Corp | $10.6M | 0.3% | NEW | 64.5 |
| 108 |  $SHAK | Shake Shack Inc. | $10.3M | 0.3% | NEW | 55.6 |
| 109 |  $SMTC | SEMTECH CORP | $10.1M | 0.3% | +1% | 55.9 |
| 110 |  $EOLS | Evolus, Inc. | $10.0M | 0.3% | +3% | 39 |
| 111 |  $DDOG | Datadog, Inc. | $9.8M | 0.3% | -82% | 71.4 |
| 112 |  $BBY | BEST BUY CO INC | $9.7M | 0.3% | +147% | 60.2 |
| 113 |  $ZURA | Zura Bio Ltd | $9.7M | 0.3% | +9% | — |
| 114 |  $EW | Edwards Lifesciences Corp | $8.9M | 0.3% | -56% | 69.4 |
| 115 |  $NVDA | NVIDIA CORP | $8.3M | 0.2% | -30% | 85.9 |
| 116 | $GTLBCALL | Gitlab Inc. | $8.2M | — | NEW | 56.8 |
| 117 |  $PEGA | PEGASYSTEMS INC | $8.2M | 0.2% | +30% | 70.4 |
| 118 |  $BL | BLACKLINE, INC. | $7.8M | 0.2% | +65% | 52.7 |
| 119 |  $ARMK | Aramark | $7.7M | 0.2% | NEW | 47.1 |
| 120 |  $RBLX | Roblox Corp | $7.6M | 0.2% | +34% | 60.3 |
| 121 |  $INGN | Inogen Inc | $7.1M | 0.2% | -9% | 31.9 |
| 122 |  $NKE | NIKE, Inc. | $7.0M | 0.2% | -28% | 49.3 |
| 123 |  $SBUX | STARBUCKS CORP | $7.0M | 0.2% | NEW | 58.2 |
| 124 | — | SPDR SERIES TRUST - ST STR SP RETAIL | $6.9M | 0.2% | NEW | — |
| 125 |  $APPN | APPIAN CORP | $6.9M | 0.2% | NEW | 52.2 |
| 126 |  $BILL | BILL Holdings, Inc. | $6.6M | 0.2% | -52% | 56 |
| 127 |  $ROST | ROSS STORES, INC. | $6.1M | 0.2% | -40% | 70.4 |
| 128 |  $RPID | RAPID MICRO BIOSYSTEMS, INC. | $5.8M | 0.2% | NEW | 26.5 |
| 129 |  $CTOR | CITIUS ONCOLOGY, INC. | $5.7M | 0.2% | -5% | — |
| 130 |  $ORLY | O REILLY AUTOMOTIVE INC | $5.3M | 0.1% | -26% | 67.4 |
| 131 | — | RTB DIGITAL INC - COM SHS | $5.3M | 0.1% | NEW | — |
| 132 |  $AMAT | APPLIED MATERIALS INC /DE | $5.1M | 0.1% | -57% | 72.3 |
| 133 |  $DWTX | Dogwood Therapeutics, Inc. | $5.0M | 0.1% | -4% | — |
| 134 |  $LIVN | LivaNova PLC | $4.8M | 0.1% | NEW | — |
| 135 |  $PONY | Pony AI Inc. | $4.5M | 0.1% | +21% | — |
| 136 |  $BTSG | BrightSpring Health Services, Inc. | $4.4M | 0.1% | NEW | 63.3 |
| 137 |  $TSEM | TOWER SEMICONDUCTOR LTD | $4.2M | 0.1% | +9% | — |
| 138 |  $MCK | MCKESSON CORP | $4.2M | 0.1% | NEW | 63.4 |
| 139 |  $ESLA | Estrella Immunopharma, Inc. | $4.1M | 0.1% | -3% | — |
| 140 |  $CRMD | CorMedix Inc. | $3.9M | 0.1% | NEW | 78.6 |
| 141 |  $LEVI | LEVI STRAUSS & CO | $3.9M | 0.1% | -28% | 63.4 |
| 142 |  $DHR | DANAHER CORP /DE/ | $3.9M | 0.1% | NEW | 64.8 |
| 143 |  $LSCC | LATTICE SEMICONDUCTOR CORP | $3.7M | 0.1% | NEW | 48.7 |
| 144 |  $STX | Seagate Technology Holdings plc | $3.7M | 0.1% | -67% | — |
| 145 |  $SNDK | Sandisk Corp | $3.7M | 0.1% | -72% | 87.7 |
| 146 |  $LRCX | LAM RESEARCH CORP | $3.6M | 0.1% | -65% | 79.4 |
| 147 |  $TTMI | TTM TECHNOLOGIES INC | $3.6M | 0.1% | NEW | 62.6 |
| 148 |  $LITE | Lumentum Holdings Inc. | $3.2M | 0.1% | -38% | 44.3 |
| 149 |  $WDC | WESTERN DIGITAL CORP | $3.2M | 0.1% | -72% | 80.7 |
| 150 |  $STM | STMicroelectronics N.V. | $3.1M | 0.1% | NEW | — |
New Positions (170)
$TVTXCALL Travere Therapeutics, Inc.$28.4M$WAT WATERS CORP /DE/$28.1M$MLYSCALL Mineralys Therapeutics, Inc.$28.1M$ILMN ILLUMINA, INC.$16.0M$PBH Prestige Consumer Healthcare Inc.$15.9M$FWONA Liberty Media Corp$15.7M$ITGR Integer Holdings Corp$15.7M$LYV Live Nation Entertainment, Inc.$15.0M$NVO NOVO NORDISK A S$15.0M$TWST Twist Bioscience Corp$14.6M$TTWO TAKE TWO INTERACTIVE SOFTWARE INC$12.5M$MRVL Marvell Technology, Inc.$11.9M$BSX BOSTON SCIENTIFIC CORP$11.3M$NOK NOKIA CORP$11.3M$NTSK Netskope Inc$10.9MExited Positions (99)
$AVNS AVANOS MEDICAL, INC.
$MDLN Medline Inc.
$KALV KalVista Pharmaceuticals, Inc.
$ENR ENERGIZER HOLDINGS, INC.$FIVNCALL Five9, Inc.
$META Meta Platforms, Inc.$PENNCALL PENN Entertainment, Inc.$CYTKPUT CYTOKINETICS INC
$ESPR Esperion Therapeutics, Inc.
$IQV IQVIA HOLDINGS INC.
$SGMO SANGAMO THERAPEUTICS, INC
$GEHC GE HealthCare Technologies Inc.
$TENX TENAX THERAPEUTICS, INC.
$NVST Envista Holdings Corp
$ICLR ICON PLCBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for ARMISTICE CAPITAL, LLC including:
Track ARMISTICE CAPITAL, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for ARMISTICE CAPITAL, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: ARMISTICE CAPITAL, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For ARMISTICE CAPITAL, LLC (SEC CIK: 1601086), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in ARMISTICE CAPITAL, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.